Page last updated: 2024-10-31

mirtazapine and AIDS-Related Opportunistic Infections

mirtazapine has been researched along with AIDS-Related Opportunistic Infections in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lanzafame, M1
Ferrari, S1
Lattuada, E1
Corsini, F1
Deganello, R1
Vento, S1
Concia, E1

Other Studies

1 other study available for mirtazapine and AIDS-Related Opportunistic Infections

ArticleYear
Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.
    Le infezioni in medicina, 2009, Volume: 17, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, H

2009